127 related articles for article (PubMed ID: 8232486)
1. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.
Kost RG; Hill EL; Tigges M; Straus SE
N Engl J Med; 1993 Dec; 329(24):1777-82. PubMed ID: 8232486
[No Abstract] [Full Text] [Related]
2. Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient.
Mouly F; Baccard M; Scieux C; Schnell L; Locq-Ebner S; Morinet F; Morel P
Dermatology; 1995; 190(2):177. PubMed ID: 7727847
[No Abstract] [Full Text] [Related]
3. Acyclovir resistant genital herpes virus infection in a patient with AIDS.
Marrero M; Alvarez M; Millan JC; Mas Lago P; Soler M; Diaz M
Acta Virol; 1991 Jan; 35(1):86-9. PubMed ID: 1683121
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women.
Gupta R; Hill EL; McClernon D; Davis G; Selke S; Corey L; Wald A
J Infect Dis; 2005 Sep; 192(6):1102-7. PubMed ID: 16107966
[TBL] [Abstract][Full Text] [Related]
5. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
6. Recurrent antiviral-resistant genital herpes in an immunocompetent patient.
Kriesel JD; Spruance SL; Prichard M; Parker JN; Kern ER
J Infect Dis; 2005 Jul; 192(1):156-61. PubMed ID: 15942905
[TBL] [Abstract][Full Text] [Related]
7. Short-course therapy for recurrent genital herpes and herpes labialis.
Spruance S; Aoki FY; Tyring S; Stanberry L; Whitley R; Hamed K
J Fam Pract; 2007 Jan; 56(1):30-6. PubMed ID: 17217895
[No Abstract] [Full Text] [Related]
8. Non-healing genital herpes mimicking donovanosis in an immunocompetent man.
Gupta V; Khute P; Patel A; Gupta S
Int J STD AIDS; 2016 Jan; 27(1):72-4. PubMed ID: 25614521
[TBL] [Abstract][Full Text] [Related]
9. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
Safrin S; Elbeik T; Mills J
J Infect Dis; 1994 Apr; 169(4):879-82. PubMed ID: 8133105
[TBL] [Abstract][Full Text] [Related]
10. [Guidelines (brief text): management of cutaneo-mucosal herpes in the immunocompetent patient (ocular manifestations excluded)].
J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1):58-67. PubMed ID: 12592186
[No Abstract] [Full Text] [Related]
11. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
Honda M; Okuda T; Hasegawa T; Kurokawa M; Shiraki K; Matsuo K; Komatsuzaki M; Niimura M
Antivir Chem Chemother; 2001 Jul; 12(4):233-9. PubMed ID: 11771732
[TBL] [Abstract][Full Text] [Related]
12. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
Baker DA
J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
[TBL] [Abstract][Full Text] [Related]
13. [Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
Baumann R; Wunderli W; Riess C; Vogt M
Schweiz Med Wochenschr; 1993 Dec; 123(51-52):2394-400. PubMed ID: 8290931
[No Abstract] [Full Text] [Related]
14. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
15. Dermacase. Can you identify this condition? Genital herpes.
Arias-Santiago S; Girón-Prieto MS; Husein-El-Ahmed H; Fernández-Pugnaire MA; Naranjo-Sintes R
Can Fam Physician; 2010 Dec; 56(12):1303-4, 1306. PubMed ID: 21156897
[No Abstract] [Full Text] [Related]
16. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
17. Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman.
Czartoski T; Liu C; Koelle DM; Schmechel S; Kalus A; Wald A
J Clin Microbiol; 2006 Apr; 44(4):1584-6. PubMed ID: 16597901
[TBL] [Abstract][Full Text] [Related]
18. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of HSV strains isolated before and after treatment with acyclovir.
Svennerholm B; Vahlne A; Löwhagen GB; Widell A; Lycke E
Scand J Infect Dis Suppl; 1985; 47():149-54. PubMed ID: 3006229
[TBL] [Abstract][Full Text] [Related]
20. Genital ulcer disease treatment policies and herpes.
O'Farrell N; Moodley P
Sex Transm Dis; 2011 Feb; 38(2):150. PubMed ID: 21209599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
